Aralez Pharma (ARLZ) Slammed, Halted Ahead of PDUFA Date

September 14, 2016 11:40 AM EDT
Get Alerts ARLZ Hot Sheet
Trade ARLZ Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Aralez Pharma (NASDAQ: ARLZ) has resumed trading and is down 14%. Today is the company's PDUFA date for YOSPRALA.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk, Trading Halts

Related Entities


Add Your Comment